Growth Metrics

Lexicon Pharmaceuticals (LXRX) EBT Margin: 2009-2011

Historic EBT Margin for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -9,867.35%.

  • Lexicon Pharmaceuticals' EBT Margin fell 803183.00% to -9,867.35% in Q4 2011 from the same period last year, while for Dec 2011 it was -6,222.71%, marking a year-over-year decrease of 420228.00%. This contributed to the annual value of -6,285.29% for FY2011, which is 421110.00% down from last year.
  • Lexicon Pharmaceuticals' EBT Margin amounted to -9,867.35% in Q4 2011, which was down 34.20% from -7,352.96% recorded in Q3 2011.
  • Lexicon Pharmaceuticals' 5-year EBT Margin high stood at -541.67% for Q1 2009, and its period low was -9,867.35% during Q4 2011.
  • Moreover, its 3-year median value for EBT Margin was -1,995.38% (2010), whereas its average is -3,442.65%.
  • Data for Lexicon Pharmaceuticals' EBT Margin shows a maximum YoY slumped of 803,183bps (in 2011) over the last 5 years.
  • Lexicon Pharmaceuticals' EBT Margin (Quarterly) stood at -729.81% in 2009, then crashed by 110,571bps to -1,835.51% in 2010, then plummeted by 803,183bps to -9,867.35% in 2011.
  • Its EBT Margin was -9,867.35% in Q4 2011, compared to -7,352.96% in Q3 2011 and -4,805.05% in Q2 2011.